Correlation Between Ironwood Pharmaceuticals and OptiNose

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ironwood Pharmaceuticals and OptiNose at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ironwood Pharmaceuticals and OptiNose into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ironwood Pharmaceuticals and OptiNose, you can compare the effects of market volatilities on Ironwood Pharmaceuticals and OptiNose and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ironwood Pharmaceuticals with a short position of OptiNose. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ironwood Pharmaceuticals and OptiNose.

Diversification Opportunities for Ironwood Pharmaceuticals and OptiNose

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ironwood and OptiNose is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Ironwood Pharmaceuticals and OptiNose in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OptiNose and Ironwood Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ironwood Pharmaceuticals are associated (or correlated) with OptiNose. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OptiNose has no effect on the direction of Ironwood Pharmaceuticals i.e., Ironwood Pharmaceuticals and OptiNose go up and down completely randomly.

Pair Corralation between Ironwood Pharmaceuticals and OptiNose

Given the investment horizon of 90 days Ironwood Pharmaceuticals is expected to generate 0.57 times more return on investment than OptiNose. However, Ironwood Pharmaceuticals is 1.76 times less risky than OptiNose. It trades about -0.16 of its potential returns per unit of risk. OptiNose is currently generating about -0.14 per unit of risk. If you would invest  415.00  in Ironwood Pharmaceuticals on August 28, 2024 and sell it today you would lose (80.00) from holding Ironwood Pharmaceuticals or give up 19.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ironwood Pharmaceuticals  vs.  OptiNose

 Performance 
       Timeline  
Ironwood Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ironwood Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
OptiNose 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OptiNose has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ironwood Pharmaceuticals and OptiNose Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ironwood Pharmaceuticals and OptiNose

The main advantage of trading using opposite Ironwood Pharmaceuticals and OptiNose positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ironwood Pharmaceuticals position performs unexpectedly, OptiNose can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OptiNose will offset losses from the drop in OptiNose's long position.
The idea behind Ironwood Pharmaceuticals and OptiNose pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume